Table 2.
Correlation coefficients between cIMT and characteristics of the groups evaluated.
| Baseline variable | cIMT (mm) | |
|---|---|---|
| r | P | |
| Age, years | 0.564 | <0.001 |
| Disease duration, years | −0.063 | 0.65 |
| DAS28, units | 0.159 | 0.26 |
| TC, mg/dL | 0.331 | 0.03 |
| Tg, mg/dL | 0.393 | 0.009 |
| HDL-c, mg/dL | −0.316 | 0.04 |
| LDL-c, mg/dL | 0.285 | 0.06 |
| VLDL-c, mg/dL | 0.270 | 0.07 |
| ox-LDL, mg/dL | 0.457 | 0.007 |
| AIP, TC/HDL-c | 0.687 | 0.01 |
| ESR, mm/h | −0.180 | 0.24 |
| RF, IU/mL | −0.001 | 0.99 |
| CRP, mg/L | 0.579 | 0.001 |
| TNFα, pg/mL | 0.552 | 0.002 |
| IL-6, pg/mL | 0.681 | <0.001 |
| Anti-CCP, U/mL | 0.393 | 0.05 |
| CD36 | −0.578 | <0.001 |
cIMT: carotid intima-media thickness; RA: rheumatoid arthritis; DAS28: disease activity score; TC: total cholesterol; Tg: triglycerides; HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; VLDL-c: very low density lipoprotein cholesterol; AIP: atherogenic index of plasma; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; CRP: C-reactive protein; TNFα: tumor necrosis factor alpha; IL-6: interleukin 6; anti-CCP: anticyclic citrullinated peptide antibodies; MFI: mean fluorescence intensity. Spearman r test.